高级检索
当前位置: 首页 > 详情页

Deficiency of inflammation-sensing protein neuropilin-2 in myeloid-derived macrophages exacerbates colitis via NF-κB activation

文献详情

资源类型:
Pubmed体系:
机构: [1]Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu, PR China. [2]Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, PR China. [3]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, PR China. [4]West China Medical Publishers, West China Hospital of Sichuan University, Chengdu, PR China. [5]Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, PR China.
出处:
ISSN:

关键词: inflammation-sensing protein colitis inflammation restriction macrophage neuropilin-2 NF-κB TNF-α inflammation myeloid cells IBD

摘要:
Neuropilin-2 (NRP2) is a multifunctional protein engaged in the regulation of angiogenesis, lymphangiogenesis, axon guidance, and tumor metastasis, but its function in colitis remains unclear. Here, we found that NRP2 was an inflammation-sensing protein rapidly and dramatically induced in myeloid cells, especially in macrophages, under inflammatory contexts. NRP2 deficiency in myeloid cells exacerbated dextran sulfate sodium salt-induced experimental colitis by promoting polarization of M1 macrophages and colon injury. Mechanistically, NRP2 could be induced via NF-κB activation by TNF-α in macrophages, but exerted an inhibitory effect on NF-κB signaling, forming a negative feedback loop with NF-κB to sense and alleviate inflammation. Deletion of NRP2 in macrophages broke this negative feedback circuit, leading to NF-κB overactivation, inflammatory exacerbation, and more severe colitis. Collectively, these findings reveal inflammation restriction as a role for NRP2 in macrophages under inflammation contexts and suggest that NRP2 in macrophages may relieve inflammation in inflammatory bowel disease. © 2023 The Pathological Society of Great Britain and Ireland.© 2023 The Pathological Society of Great Britain and Ireland.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 1 区 病理学 2 区 肿瘤学
最新[2023]版:
大类 | 2 区 医学
小类 | 1 区 病理学 2 区 肿瘤学
第一作者:
第一作者机构: [1]Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu, PR China. [2]Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, PR China. [3]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, PR China. [4]West China Medical Publishers, West China Hospital of Sichuan University, Chengdu, PR China.
共同第一作者:
通讯作者:
通讯机构: [1]Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu, PR China. [2]Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, PR China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46425 今日访问量:0 总访问量:3323 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号